Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.（RIGL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rigl · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$42.00
Consensus
$27.33
-8.9% upside
Low
$2.00
Median: $38 · Last Close: $30.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$27.33
-8.9% upside
High Target
$42
39.9%
Low Target
$2
-93.3%
Current Price
$30.01
as of today
Based on analyst price targets, the RIGL stock price prediction for the next 12 months ranges from $2 to $42. The consensus RIGL price forecast of $27.33 implies -8.9% upside from the current price of $30.01.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $30.31 | ↑ 0.98% |
1-day model range: $30.1–$30.52. Peak: $30.52 (+0.98%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $32 | +7.5% |
| 2028 | $34 | +11.9% |
| 2029 | $34 | +14.5% |
| 2030 | $35 | +15.9% |
| 2031 | — | +16.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RIGL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | Citigroup | Maintains | Buy→Buy |
| 2026-05-07 | Citigroup | Maintains | Buy→Buy |
| 2025-11-05 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2025-11-05 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2025-10-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-06 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2025-05-07 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Rigel Pharmaceuticals, Inc. (RIGL) stock. Of the recent 95 rating actions, 4 were upgrades and 9 were downgrades. 15 analysts currently cover RIGL.
分析师推荐趋势
RIGL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$270M
↓ 27.2% YoY
Revenue Next Year
$330M
↑ 22.2% YoY
EPS This Year
$3.15
EPS Next Year
$4.38
↑ 39.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast RIGL EPS of $3.15 for the current fiscal year, based on estimates from 3 analysts. The RIGL revenue forecast is $270M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RIGL 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RIGL 的共识目标价为 $27.33（-8.9% 上行空间），分析师共识为 Buy。
RIGL 的短期预测（明日）为 $30.31（+0.98%）。 RIGL 对 2027 年的股价预测均值为 $32。 RIGL 对 2030 年的预测区间为 $32–$37。
Rigel Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 RIGL。RIGL 在 2027 年的整体展望偏积极，在覆盖分析师中约 53% 对应 Buy 共识。
常见问题
RIGL 预测 · 8 个问题根据 15 位华尔街分析师，RIGL 的 12 个月平均目标价为 $27.33，最高 $42.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $30.01，隐含约 -8.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.